AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Company Description
Stryker Corporation operates as a medical technology company.
The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine.
The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries.
This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies.
The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties.
This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants.
The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries.
Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.
Country | United States |
IPO Date | Mar 17, 1980 |
Industry | Medical - Devices |
Sector | Healthcare |
Employees | 52,000 |
CEO | Kevin A. Lobo |
Contact Details
Address: 2825 Airview Boulevard Kalamazoo, Michigan United States | |
Website | https://www.stryker.com |
Stock Details
Ticker Symbol | SYK |
Exchange | NYSE |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0000310764 |
CUSIP Number | 863667101 |
ISIN Number | US8636671013 |
Employer ID | 38-1239739 |
SIC Code | 3841 |
Key Executives
Name | Position |
---|---|
Kevin A. Lobo | Chairman, Chief Executive Officer & President |
Alan Douville | Vice President, Chief Information Officer & Chief Information Security Officer |
Robert C. Cohen | Chief Technology Officer and Vice President of Global R&D - Joint Replacement |
Robert S. Fletcher | Vice President & Chief Legal Officer |
Dana S. McMahon | Vice President & Chief Compliance Officer |
J. Andrew Pierce | Group President of MedSurg & Neurotechnology |
Jason Beach | Vice President of Finance & Investor Relations |
Spencer S. Stiles | Group President of Orthopaedics & Spine |
Viju S. Menon | Group President of Global Quality & Operations |
William E. Berry Jr. | Vice President & Chief Accounting Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Jan 02, 2025 | 4 | Filing |
Dec 30, 2024 | 4 | Filing |
Dec 26, 2024 | 4 | Filing |
Dec 18, 2024 | 4 | Filing |
Dec 03, 2024 | 25-NSE | Filing |
Nov 19, 2024 | 4 | Filing |
Nov 18, 2024 | 4 | Filing |
Nov 08, 2024 | 4 | Filing |
Nov 07, 2024 | 4 | Filing |
Nov 05, 2024 | 4 | Filing |